FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology, and may be used in treating eyelid cancer for prevention of obliteration of the lachrymal ducts. That is ensured by irrigation of the nasolachrymal duct twice a day before each session radiation therapy and in 10-12 days after the session. A solution containing 0.1% dexamethasone min. 2.0 ml and methotrexate 5 mg is injected in the nasolachrymal duct in a lower nasal point through a blunt-ended cannula on a syringe.
EFFECT: method provides prevention of such bothersome symptom as permanent lachrymation, as well as maintenance of light-refringent, protective function of the lachrymal organs, and finally - maintenance of visual functions.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING EYELID MALIGNANCIES | 2010 |
|
RU2445086C1 |
METHOD FOR COMPLEX THERAPY IN PATIENTS WITH SKIN MELANOMA | 2006 |
|
RU2318452C1 |
METHOD FOR PREPARING UTERINE NECK CARCINOMA PATIENTS OF THE III STAGE FOR MAKING OPERATION | 1996 |
|
RU2149661C1 |
METHOD OF ELIMINATION OF EYELID DEFECTS AND FACE SURROUNDING ZONES AFTER REMOVING TUMORS OF THIS ZONE | 2017 |
|
RU2670659C1 |
METHOD FOR TREATMENT OF PELVIC ORGANS RADIATION DAMAGE | 2016 |
|
RU2647423C2 |
METHOD FOR PREDICTING COMPLICATIONS OCCURRENCE IN PERFORMING ANTITUMOR TREATMENT | 1995 |
|
RU2107918C1 |
WAY TO DIFFERENTIATE DETERMINING THE INDICATIONS FOR TREATMENT OF CHILDREN WITH PATHOLOGY OF LACHRYMAL PASSAGE | 2015 |
|
RU2583145C1 |
METHOD FOR CONSERVATIVE TREATMENT IN PATIENTS AT NONOPERABLE PULMONARY CARCINOMA | 2005 |
|
RU2311185C2 |
METHOD OF CLOSING BILATERAL TOTAL DEFECT OF BOTH EYELIDS, INTERNAL AND EXTERNAL ANGLES OF EYE | 2010 |
|
RU2446776C1 |
METHOD FOR TREATING THE CASES OF LUNG CANCER | 2003 |
|
RU2242936C1 |
Authors
Dates
2012-03-27—Published
2010-07-26—Filed